Bank Julius Baer & Co. Ltd, Zurich Moderna, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$23.9 Billion
Q2 2024

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Moderna, Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 199,692 shares of MRNA stock, worth $13.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

199,692

Previous 233,824 14.6%

Holding current value

$13.1 Million

Previous $24.9 Million 4.83%

% of portfolio

0.1%

Previous 0.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $3.45 Million - $5.69 Million	-34,132 Reduced 14.6%	199,692 $23.7 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $2.67 Million - $3.61 Million	31,300 Added 15.45%	233,824 $24.9 Million
Q4 2023 May 16, 2024	BUY	$69.51 - $104.43 $13.9 Million - $20.9 Million	200,024 Added 8000.96%	202,524 $20.1 Million
Q4 2023 May 16, 2024	SELL	$69.51 - $104.43 $16.1 Million - $24.2 Million	-231,324 Reduced 98.93%	2,500 $248,000
Q4 2023 Feb 02, 2024	BUY	$69.51 - $104.43 $4.83 Million - $7.25 Million	69,441 Added 52.18%	202,524 $20.1 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $933,055 - $1.23 Million	-9,678 Reduced 6.78%	133,083 $13.7 Million
Q2 2023 Jul 24, 2023	BUY	$118.5 - $160.53 $16.9 Million - $22.9 Million	142,761 New	142,761 $17.3 Million
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $435,061 - $631,843	-3,207 Reduced 2.16%	145,005 $22.3 Million
Q4 2022 Jan 24, 2023	SELL	$118.38 - $210.04 $764,734 - $1.36 Million	-6,460 Reduced 4.18%	148,212 $26.6 Million
Q3 2022 Nov 04, 2022	SELL	$118.07 - $194.18 $5 Million - $8.23 Million	-42,365 Reduced 21.5%	154,672 $18.3 Million
Q2 2022 Jul 22, 2022	SELL	$117.13 - $176.59 $1.17 Million - $1.77 Million	-10,001 Reduced 4.83%	197,037 $28.1 Million
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $1.59 Million - $2.95 Million	-12,542 Reduced 5.71%	207,038 $35.7 Million
Q4 2021 Feb 15, 2022	SELL	$225.82 - $368.51 $957,928 - $1.56 Million	-4,242 Reduced 1.9%	219,580 $55.8 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $10.2 Million - $22.2 Million	-45,895 Reduced 17.02%	223,822 $86.1 Million
Q2 2021 Jul 23, 2021	BUY	$129.91 - $234.98 $618,891 - $1.12 Million	4,764 Added 1.8%	269,717 $63.4 Million
Q1 2021 May 10, 2021	SELL	$109.18 - $185.98 $15.8 Million - $26.9 Million	-144,782 Reduced 35.34%	264,953 $34.7 Million
Q4 2020 Feb 24, 2021	SELL	$65.74 - $169.86 $241 Million - $622 Million	-3,660,983 Reduced 89.93%	409,735 $42.8 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $241 Million - $624 Million	3,673,387 Added 924.52%	4,070,718 $42.8 Million
Q3 2020 Nov 10, 2020	SELL	$54.34 - $94.85 $7.38 Million - $12.9 Million	-135,810 Reduced 25.47%	397,331 $28.1 Million
Q2 2020 Aug 12, 2020	SELL	$29.67 - $80.0 $7.68 Million - $20.7 Million	-258,938 Reduced 32.69%	533,141 $34.2 Million
Q1 2020 May 13, 2020	BUY	$17.78 - $31.58 $14.1 Million - $25 Million	792,079 New	792,079 $23.7 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account

Bank Julius Baer & Co. Ltd, Zurich Moderna, Inc. Transaction History